These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24326340)

  • 1. Inhibition of indoleamine 2,3-dioxygenase by thielavin derivatives from a soil fungus, Coniochaeta sp. 10F058.
    Jang JP; Jang JH; Oh M; Son S; Kim SM; Kim HM; Shin KS; Oh H; Soung NK; Hong YS; Kim BY; Ahn JS
    J Antibiot (Tokyo); 2014 Apr; 67(4):331-3. PubMed ID: 24326340
    [No Abstract]   [Full Text] [Related]  

  • 2. Research progress of indoleamine 2,3-dioxygenase inhibitors.
    Jiang T; Sun Y; Yin Z; Feng S; Sun L; Li Z
    Future Med Chem; 2015; 7(2):185-201. PubMed ID: 25686005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRM646-A and -B, novel fungal metabolites that inhibit heparinase.
    Ko HR; Kim BY; Oh WK; Kang DO; Lee HS; Koshino H; Osada H; Mheen TI; Ahn JS
    J Antibiot (Tokyo); 2000 Feb; 53(2):211-4. PubMed ID: 10805586
    [No Abstract]   [Full Text] [Related]  

  • 4. Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
    Yang S; Li X; Hu F; Li Y; Yang Y; Yan J; Kuang C; Yang Q
    J Med Chem; 2013 Nov; 56(21):8321-31. PubMed ID: 24099220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thielavins A, J and K: α-Glucosidase inhibitors from MEXU 27095, an endophytic fungus from Hintonia latiflora.
    Rivera-Chávez J; González-Andrade M; González Mdel C; Glenn AE; Mata R
    Phytochemistry; 2013 Oct; 94():198-205. PubMed ID: 23809634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of telomerase activity by fungus metabolites, CRM646-A and thielavin B.
    Togashi K; Ko HR; Ahn JS; Osada H
    Biosci Biotechnol Biochem; 2001 Mar; 65(3):651-3. PubMed ID: 11330682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marine natural products and other derivatives as potent indoleamine 2,3-dioxygenase inhibitors.
    Delfourne E
    Mini Rev Med Chem; 2012 Sep; 12(10):988-96. PubMed ID: 22512584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors.
    Cheng MF; Hung MS; Song JS; Lin SY; Liao FY; Wu MH; Hsiao W; Hsieh CL; Wu JS; Chao YS; Shih C; Wu SY; Ueng SH
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3403-6. PubMed ID: 24939758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.
    Yue EW; Douty B; Wayland B; Bower M; Liu X; Leffet L; Wang Q; Bowman KJ; Hansbury MJ; Liu C; Wei M; Li Y; Wynn R; Burn TC; Koblish HK; Fridman JS; Metcalf B; Scherle PA; Combs AP
    J Med Chem; 2009 Dec; 52(23):7364-7. PubMed ID: 19507862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.
    Dolušić E; Larrieu P; Blanc S; Sapunaric F; Pouyez J; Moineaux L; Colette D; Stroobant V; Pilotte L; Colau D; Ferain T; Fraser G; Galleni M; Frère JM; Masereel B; Van den Eynde B; Wouters J; Frédérick R
    Eur J Med Chem; 2011 Jul; 46(7):3058-65. PubMed ID: 21419531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of flavonoids isolated from
    Kwon M; Ko SK; Jang M; Kim GH; Ryoo IJ; Son S; Ryu HW; Oh SR; Lee WK; Kim BY; Jang JH; Ahn JS
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1481-1488. PubMed ID: 31423846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exiguamine A, an indoleamine-2,3-dioxygenase (IDO) inhibitor isolated from the marine sponge Neopetrosia exigua.
    Brastianos HC; Vottero E; Patrick BO; Van Soest R; Matainaho T; Mauk AG; Andersen RJ
    J Am Chem Soc; 2006 Dec; 128(50):16046-7. PubMed ID: 17165752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoleamine 2,3-dioxygenase inhibitors: a patent review (2008 - 2012).
    Dolušić E; Frédérick R
    Expert Opin Ther Pat; 2013 Oct; 23(10):1367-81. PubMed ID: 23992582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Röhrig UF; Majjigapu SR; Vogel P; Zoete V; Michielin O
    J Med Chem; 2015 Dec; 58(24):9421-37. PubMed ID: 25970480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel hydroxyamidine derivatives as indoleamine 2,3-dioxygenase 1 inhibitors with in vivo anti-tumor efficacy.
    Liu C; Nan Y; Xia Z; Gu K; Chen C; Dong X; Ju D; Zhao W
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127038. PubMed ID: 32088128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiosemicarbazide, a fragment with promising indolamine-2,3-dioxygenase (IDO) inhibition properties.
    Serra S; Moineaux L; Vancraeynest C; Masereel B; Wouters J; Pochet L; Frédérick R
    Eur J Med Chem; 2014 Jul; 82():96-105. PubMed ID: 24878638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Inhibitors of Indoleamine 2,3-Dioxygenase 1: Molecular Modeling Studies, Synthesis, and Biological Evaluation.
    Coluccia A; Passacantilli S; Famiglini V; Sabatino M; Patsilinakos A; Ragno R; Mazzoccoli C; Sisinni L; Okuno A; Takikawa O; Silvestri R; La Regina G
    J Med Chem; 2016 Nov; 59(21):9760-9773. PubMed ID: 27690429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors.
    Huang Q; Zheng M; Yang S; Kuang C; Yu C; Yang Q
    Eur J Med Chem; 2011 Nov; 46(11):5680-7. PubMed ID: 21925773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evading immunity: new enzyme implicated in cancer.
    Garber K
    J Natl Cancer Inst; 2012 Mar; 104(5):349-52. PubMed ID: 22349199
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and biological evaluation of novel tryptoline derivatives as indoleamine 2,3-dioxygenase (IDO) inhibitors.
    Tanaka M; Li X; Hikawa H; Suzuki T; Tsutsumi K; Sato M; Takikawa O; Suzuki H; Yokoyama Y
    Bioorg Med Chem; 2013 Mar; 21(5):1159-65. PubMed ID: 23337802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.